To identify whether S63845, in addition to binding and inhibiting MCL-1, can also potentially bind and inhibit BCL-2, we exposed primary CLL cells that exclusively depend on BCL-2 for survival, [8] to increasing concentrations of S63845 and A-1210477. This evidence concerns the gene MCL1 and B-cell chronic lymphocytic leukemia.